The Entheogenic Plant and Fungus Policy Act — DC voters made natural psychedelics the lowest police priority in 2020.
DC Initiative 81 made police enforcement against natural psychedelics the lowest priority in Washington, D.C. Voters approved it on November 3, 2020, with about 76% support. Its official name is the Entheogenic Plant and Fungus Policy Act of 2020.
The measure did not change any criminal penalty. Instead, it directs the Metropolitan Police Department to treat non-commercial use, possession, and cultivation of entheogenic plants and fungi as among its lowest enforcement priorities. It applies to people 18 and older.
Initiative 81 also makes a non-binding public call. It asks the DC Attorney General and the US Attorney for the District of Columbia to stop prosecuting residents for these activities. That request carries no legal force.
DC Initiative 81 was the largest jurisdiction to deprioritize natural psychedelics when it passed, with millions of residents and visitors. It is a national symbol because it sits in the nation's capital, next to Congress. But its real reach is narrower than its symbolism, and that gap is the most misunderstood part of the law.
Initiative 81 covers plants and fungi that naturally contain ibogaine, DMT, mescaline, psilocybin, or psilocyn. These are the same compounds DC already lists as Schedule I controlled substances. The measure groups them together as "entheogenic plants and fungi."
In everyday terms, that means:
Initiative 81 changed police priorities, not the law itself. The clearest way to read it is as a short list of what shifted against a longer list of what did not. The table below sorts the two.
| Activity | What Initiative 81 changed | What stayed illegal |
|---|---|---|
| Personal use & possession | Lowest police priority for adults 18+ | Still illegal; not legalized |
| Growing for yourself | Non-commercial cultivation deprioritized | Still a controlled substance under DC law |
| Sharing without payment | Non-commercial "practices" deprioritized | Any sale or commercial exchange stays a target |
| Selling or a store model | No change — not deprioritized | Fully illegal; no dispensaries or licensed centers |
| Federal law | No change | Schedule I; illegal nationwide and on federal land |
So the headline is simple. Initiative 81 lowered the odds that DC police pursue an adult for personal, non-commercial activity. It did not make any psychedelic legal, and it created no place to buy them.
DC Initiative 81 is weaker than a state decriminalization law because Washington, D.C. is not a state. The District has no full sovereignty over its own criminal law, and a large share of its land falls under federal control. Both facts limit what a local ballot measure can deliver.
Congress has direct power over DC under the Constitution. Every DC law, including Initiative 81, must pass a Congressional review period before it takes effect. The measure was sent to Congress for a 30-legislative-day review and only took effect on March 15, 2021, after the review ended with no objection.
Congress can also block DC drug policy through spending riders. A long-running rider has limited how DC spends money to change the legal status of Schedule I drugs. That is one reason Initiative 81 was written as an enforcement-priority measure rather than a tax-and-regulate program — the structure sidesteps a restriction that a Colorado-style commercial market could not.
Denver Initiative 301 and DC Initiative 81 are both deprioritization measures, but they differ in scope and reach. Denver moved first in 2019 and covered only mushrooms; DC followed in 2020 with a broader plant-and-fungus list. The table compares the two.
| Feature | Denver Initiative 301 (2019) | DC Initiative 81 (2020) |
|---|---|---|
| Substances covered | Psilocybin mushrooms only | Psilocybin, DMT, mescaline, ibogaine plants & fungi |
| Minimum age | Adults 21+ | Adults 18+ |
| Legal status | Deprioritized, still illegal | Deprioritized, still illegal |
| Federal/Congressional layer | None — Denver is a city in a state | Congressional review + federal land jurisdiction |
| Retail or licensed access | None | None |
When the distinction matters: if you only care about mushrooms, the two read alike. If you care about ayahuasca, mescaline, or iboga, only DC's list reaches them. For the full picture of where these measures sit nationally, see our roundup of US cities that decriminalized psilocybin and the Denver Initiative 301 guide.
Initiative 81 does not make Washington, D.C. a place to buy or freely use psychedelics. There is no store, no mail order, no licensed center, and no public-use right. The substances remain illegal; police are simply told to look elsewhere first for non-commercial cases.
Selling stays fully illegal and is not deprioritized. Sharing for money, driving under the influence, and any conduct involving minors all stay enforceable. So does possession on federal land, which is common in DC.
For how the rest of the country compares, check our legal status by state tool and the US psychedelic legal map. Both show where deprioritization, decriminalization, and regulated programs each apply.
No. Psilocybin mushrooms, ayahuasca, mescaline cacti, and iboga are still illegal in Washington, D.C., and remain Schedule I under federal law. DC Initiative 81 only made police enforcement against non-commercial personal use the lowest priority for the Metropolitan Police Department. It did not legalize anything.
It directs DC police to treat non-commercial use, possession, and cultivation of entheogenic plants and fungi by adults 18+ as among their lowest enforcement priorities. It also makes a non-binding call on the DC and US Attorneys to stop prosecuting these activities. It is deprioritization, not legalization.
Voters approved it on November 3, 2020, with about 76% in favor (214,685 yes to 67,140 no). Because Congress reviews DC laws, it was sent for a 30-legislative-day review and took effect on March 15, 2021, after the review ended with no objection.
It covers plants and fungi that naturally contain ibogaine, DMT, mescaline, psilocybin, or psilocyn. In practice that means psilocybin mushrooms, ayahuasca and DMT plants, mescaline cacti, and iboga. It does not cover synthetics like LSD or MDMA.
No. There are no legal stores, dispensaries, or licensed centers for psychedelics in DC. Initiative 81 only lowered the enforcement priority for non-commercial activity. Selling stays illegal and is not deprioritized.
Denver Initiative 301 (2019) deprioritized only psilocybin mushrooms for adults 21+, while DC Initiative 81 (2020) covers a broader group of entheogenic plants and fungi, including ayahuasca, mescaline cacti, and iboga, for adults 18+. Both are deprioritization, not legalization, and DC adds a Congressional-review layer Denver does not have.
Deprioritization, decriminalization, and regulated access all mean different things. Our tools show exactly which rules apply where you are.
Get DC Initiative 81 updates
New votes, rules, court rulings, and access changes for DC Initiative 81 — delivered when they happen.
← Back to all psychedelic laws
Suggest a tool, topic, or improvement that would make this site more useful.